Upregulation of IGF2 is associated with an acquired resistance for cis-diamminedichloroplatinum in human head and neck squamous cell carcinoma

European Archives of Oto-Rhino-Laryngology

Volumn 267, Issue 10, 2010, Pages 1599-1606

  Ogawa, Takenori ^a   Ogawa, Kazumi ^a   Shiga, Kiyoto ^a   Furukawa, Toru ^a   Nagase, Hiroki ^b   Hashimoto, Sho ^a   Kobayashi, Toshimitsu ^a   Horii, Akira ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CDDP; Chemoresistance; Chemosensitivity; HNSCC; IGF2; Microarray

Indexed keywords

CISPLATIN; SMALL INTERFERING RNA; SOMATOMEDIN B;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SENSITIVITY; GENE CLUSTER; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HEAD AND NECK NEOPLASMS; HUMANS; INSULIN-LIKE GROWTH FACTOR II; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 77957202137     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-010-1257-4     Document Type: Article

References (33)

1. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base, No5, ver. 20. IARC Press, Lyon
2. AA Forastiere H Goepfert M Maor TF Pajak R Weber W Morrison B Glisson A Trotti JA Ridge C Chao G Peters DJ Lee A Leaf J Ensley J Cooper 2003 Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2091 2098 10.1056/NEJMoa031317 1:CAS:528: DC%2BD3sXptlKiu7s%3D 14645636 (Pubitemid 37464533)
3. DJ Adelstein Y Li GL Adams H Wagner Jr JA Kish JF Ensley DE Schuller AA Forastiere 2003 An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 92 98 10.1200/JCO.2003.01. 008 12506176
4. J Bernier C Domenge M Ozsahin K Matuszewska JL Lefèbvre RH Greiner J Giralt P Maingon F Rolland M Bolla F Cognetti J Bourhis A Kirkpatrick M van Glabbeke 2004 European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 1945 1952 10.1056/NEJMoa032641 1:CAS:528:DC%2BD2cXjslehsrk%3D 15128894 (Pubitemid 38580197)
5. T Ogawa T Furukawa K Shiga S Hashimoto K Ogawa T Kobayashi A Horii 2010 A cDNA microarray analysis identifies 52 genes associated with CDDP susceptibility in head and neck squamous cell carcinoma cell lines Eur Arch Otorhinolaryngol 267 123 129 10.1007/s00405-009-0976-x
6. EE Higuchi N Oridate Y Furuta S Suzuki H Hatakeyama H Sawa K Sunayashiki-Kusuzaki K Yamazaki Y Inuyama S Fukuda 2003 Differentially expressed genes associated with CIS-diamminedichloroplatinum (II) resistance in head and neck cancer using differential display and cDNA microarray Head Neck 25 187 193 10.1002/hed.10204 12599285 (Pubitemid 36245876)
7. SL Hockley K Mathijs YC Staal D Brewer I Giddings JH van Delft DH Phillips 2009 Interlaboratory and interplatform comparison of microarray gene expression analysis of HepG2 cells exposed to benzo(a)pyrene OMICS 13 115 125 10.1089/omi.2008.0060 1:CAS:528:DC%2BD1MXkt1Chu7w%3D 19245359
8. I Iwasaki H Sugiyama S Kanazawa H Hemmi 2002 Establishment of cisplatin-resistant variant of human nouroblastoma cell lines, TWG and GOTO, and their drug cross resistance profiles Cancer Chemother Pharmacol 49 438 444 10.1007/s00280-002-0452-4 1:CAS:528:DC%2BD38XksFOnt78%3D 12107547 (Pubitemid 34671278)
9. O Tounekti J Belehradek Jr LM Mir 1995 Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosis Exp Cell Res 217 506 516 10.1006/excr.1995.1116 1:CAS:528:DyaK2MXkslyrtLw%3D 7535239
10. S Yamanaka M Sunamura T Furukawa L Sun LP Lefter T Abe T Yatsuoka H Fujimura E Shibuya N Kotobuki M Oshimura A Sakurada M Sato T Kondo S Matsuno A Horii 2004 Chromosome 12, frequently deleted in human pancreatic cancer, may encode a tumor suppressor gene that suppresses angiogenesis Lab Invest 84 1339 1351 10.1038/labinvest.3700160 1:CAS:528:DC%2BD2cXovVaitr0%3D 15300227 (Pubitemid 40063698)
11. T Furukawa N Kanai HO Shiwaku N Soga A Uehara A Horii 2006 AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer Oncogene 25 4831 4839 10.1038/sj.onc.1209494 1:CAS:528:DC%2BD28XnvVyltrw%3D 16532023 (Pubitemid 44201174)
12. Y Mori H Shiwaku S Fukushige S Wakatsuki M Sato T Nukiwa A Horii 1997 Alternative splicing of hMSH2 in normal human tissues Hum Genet 99 590 595 10.1007/s004390050411 1:CAS:528:DyaK2sXjtl2ltb4%3D 9150723 (Pubitemid 27192587)
13. S Xu T Furukawa N Kanai M Sunamura A Horii 2005 Abrogation of DUSP6 by hypermethylation in human pancreatic cancer J Hum Genet 50 159 167 10.1007/s10038-005-0235-y 1:CAS:528:DC%2BD2MXjvFKru7c%3D 15824892 (Pubitemid 40685330)
14. K Ogawa K Shiga S Saijo T Ogawa N Kimura A Horii 2006 A novel G106D alteration of the SDHD gene in a pedigree with familial paraganglioma Am J Med Genet A 140 2441 2446 17041923
15. E Kondo A Horii S Fukushige 1999 The human PMS2L proteins do not interact with hMLH1, a major DNA mismatch repair protein J Biochem 125 818 825 1:CAS:528:DyaK1MXjsVyrtbY%3D 10101297
16. T Yatsuoka T Furukawa M Sunamura S Matsuno A Horii 2004 TU12B1-TY, a novel gene in the region at 12q22-q23.1 frequently deleted in pancreatic cancer, shows reduced expression in pancreatic cancer cells Oncol Rep 12 1263 1268 1:CAS:528:DC%2BD2MXitFOltQ%3D%3D 15547748
17. PA Andrews SB Howell 1990 Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance Cancer Cells 2 35 43 1:CAS:528:DyaK3cXhvFWiurs%3D 2204382
18. LK Hoskins RD Whelan SA Shellard P Bedford BT Hill 1990 An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumor agents shown by a range of human tumour cell lines Biochem Pharmacol 40 1833 1842 10.1016/0006-2952(90)90364-Q (Pubitemid 20337966)
19. GA Hospers C Meijer L de Leij DR Uges NH Mulder EG de Vries 1990 A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance Int J Cancer 46 138 144 10.1002/ijc.2910460125 1:CAS:528:DyaK3MXhtFClur8%3D 2163989 (Pubitemid 20225800)
20. C Meijer NH Mulder H Timmer-Bosscha WJ Sluiter GJ Meersma EG de Vries 1992 Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds Cancer Res 52 6885 6889 1:CAS:528:DyaK3sXlt1SjtA%3D%3D 1458477
21. KT Robbins D Vicario S Seagren R Weisman P Pellitteri C Kerber L Orloff G Los SB Howell 1994 A targeted superdose cisplatin chemoradiation protocol for advanced head and neck cancer Am J Surg 168 419 422 10.1016/S0002-9610(05)80089- 3 1:STN:280:DyaK2M%2FmvVKjtA%3D%3D 7977964 (Pubitemid 24345687)
22. N Eckstein K Servan B Hildebrandt A Pölitz G von Jonquières S Wolf-Kümmeth I Napierski A Hamacher MU Kassack J Budczies M Beier M Dietel B Royer-Pokora C Denkert HD Royer 2009 Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells Cancer Res 69 2996 3003 10.1158/0008-5472. CAN-08-3153 1:CAS:528:DC%2BD1MXjvVWisbw%3D 19318572
23. O Ogawa MR Eccles J Szeto LA McNoe K Yun MA Maw PJ Smith AE Reeve 1993 Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour Nature 362 749 751 10.1038/362749a0 1:CAS:528:DyaK3sXisFansL4%3D 8097018 (Pubitemid 23125978)
24. SN Sait NJ Nowak P Singh-Kahlon R Weksberg J Squire TB Shows MJ Higgins 1994 Localization of Beckwith-Wiedemann and rhabdoid tumor chromosome rearrangements to a defined interval in chromosome band 11p15.5 Genes Chromosomes Cancer 11 97 105 10.1002/gcc.2870110206 1:CAS:528:DyaK2MXhvVKhsbo%3D 7529555
25. R Winkler L Delacroix K Bensbaho S Lambert J Collette D Hodzic 1999 IGF-II in primary human colorectal tumors: Peptide level, activated promoters, parental imprinting and gene rearrangement Horm Metab Res 31 148 154 10.1055/s-2007-978713 1:CAS:528:DyaK1MXitlKlu7s%3D 10226796
26. W Xu H Fan X He J Zhang W Xie 2006 LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR J Exp Clin Cancer Res 25 543 547 1:CAS:528:DC%2BD2sXhvFyks7Y%3D 17310846
27. D LeRoith CT Roberts Jr 2003 The insulin-like growth factor system and cancer Cancer Lett 195 127 137 1:CAS:528:DC%2BD3sXktFWmsrk%3D 12767520
28. SL Anzick J Kononen RL Walker DO Azorsa MM Tanner XY Guan G Sauter OP Kallioniemi JM Trent 1997 Meltzer PS, AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer Science 277 965 968 10.1126/science.277. 5328.965 1:CAS:528:DyaK2sXltlGjtLc%3D 9252329 (Pubitemid 27366683)
29. H Chen RJ Lin RL Schiltz D Chakravarti A Nash L Nagy ML Privalsky Y Nakatani RM Evans 1997 Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 Cell 90 569 580 10.1016/S0092-8674(00)80516-4 1:CAS:528: DyaK2sXlsVKrsLw%3D 9267036 (Pubitemid 27347246)
30. L Cartee GL Kucera 2000 Protein kinase C modulation and anticancer drug response Cancer Invest 18 731 739 10.3109/07357900009012205 1:CAS:528: DC%2BD3cXos1Oqtro%3D 11107443
31. J Beck B Bohnet D Brügger P Bader J Dietl RJ Scheper R Kandolf C Liu D Niethammer V Gekeler 1998 Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression Br J Cancer 77 87 91 1:CAS:528: DyaK1cXoslertw%3D%3D 9459150
32. JF Beck B Bohnet D Brügger J Dietl RJ Scheper P Bader D Niethammer V Gekeler 1998 Expression analysis of protein kinase C isozymes and multidrug resistance associated genes in ovarian cancer cells Anticancer Res 18 701 705 1:CAS:528:DyaK1cXjvFKgsLk%3D 9615708
33. J Sonnemann V Gekeler K Ahlbrecht K Brischwein C Liu P Bader C Müller D Niethammer JF Beck 2004 Down-regulation of protein kinase Ceta by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel Cancer Lett 209 177 185 10.1016/j.canlet.2004.02.001 1:CAS:528:DC%2BD2cXktF2lu7s%3D 15159020 (Pubitemid 38670487)